NYSE:NUSNu Skin Enterprises Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Nu Skin Enterprises, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $37.18 +0.35 (+0.95 %) (As of 05/29/2020 04:00 PM ET) Add Compare Share Today's Range$36.42Now: $37.18▼$37.5750-Day Range$22.17MA: $29.63▼$38.3352-Week Range$12.31Now: $37.18▼$52.00Volume487,864 shsAverage Volume976,935 shsMarket Capitalization$1.93 billionP/E Ratio13.77Dividend Yield4.07%Beta1.1 ProfileAnalyst RatingsAdvanced ChartCompetitorsDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Nu Skin Enterprises, Inc. develops and distributes anti-aging personal care products and nutritional supplements under the Nu Skin and Pharmanex category brands worldwide. It provides skin care systems, including ageLOC Me customized skin care systems, ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products, as well as a range of other cosmetic and personal care products. The company also offers ageLOC Youth nutritional supplements, ageLOC TR90 weight management and body shaping systems, and LifePak nutritional supplements, as well as other anti-aging nutritional solutions and weight management products. In addition, it is involved in the research and product development of skin care products and nutritional supplements. Further, the company operates walk-in centers and pick-up locations; and retail stores and service centers in Mainland China. The company sells its products directly, as well as through distributors and Website. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.Read More Beat the Market (BTM) Rank™ 1.0 Analyst's Opinion Consensus RatingNu Skin Enterprises has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on 1 buy rating, 5 hold ratings, and 1 sell rating.Price Target Upside/DownsideAccording to analysts' consensus price target of $40.57, Nu Skin Enterprises has a potential upside of 9.1% from its current price of $37.18.Amount of Analyst CoverageNu Skin Enterprises has only been the subject of 2 research reports in the past 90 days. Previous Next 2.6 Community Rank Outperform VotesNu Skin Enterprises has received 490 “outperform” votes. (Add your “outperform” vote.)Underperform VotesNu Skin Enterprises has received 467 “underperform” votes. (Add your “underperform” vote.)Community SentimentNu Skin Enterprises has received 51.20% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Nu Skin Enterprises and other stocks. Vote “Outperform” if you believe NUS will outperform the S&P 500 over the long term. Vote “Underperform” if you believe NUS will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 5.0 Dividend Strength Dividend LeadershipNu Skin Enterprises is a leading dividend payer. It pays a dividend yield of 4.07%, putting its dividend yield in the top 25% of dividend-paying stocks.Dividend GrowthNu Skin Enterprises has been increasing its dividend for 19 years.Dividend CoverageThe dividend payout ratio of Nu Skin Enterprises is 48.39 %. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, Nu Skin Enterprises will have a dividend payout ratio of 55.97 % next year. This indicates that Nu Skin Enterprises will be able to sustain or increase its dividend. Previous Next 4.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Nu Skin Enterprises insiders have bought more of their company's stock than they have sold. Specifically, they have bought $202,500.00 in company stock and sold $0.00 in company stock.Percentage Held by InsidersOnly 3.40% of the stock of Nu Skin Enterprises is held by insiders.Percentage Held by Institutions75.84% of the stock of Nu Skin Enterprises is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 2.5 Earnings and Valuation Earnings GrowthEarnings for Nu Skin Enterprises are expected to grow by 21.27% in the coming year, from $2.21 to $2.68 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Nu Skin Enterprises is 13.77, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 15.33.Price to Earnings Ratio vs. SectorThe P/E ratio of Nu Skin Enterprises is 13.77, which means that it is trading at a less expensive P/E ratio than the Consumer Staples sector average P/E ratio of about 36.92.Price to Earnings Growth RatioNu Skin Enterprises has a PEG Ratio of 10.27. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioNu Skin Enterprises has a P/B Ratio of 2.41. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next Analyst Opinion: 1.0Community Rank: 2.6Dividend Strength: 5.0Insider Behavior: 4.0Valuation: 2.5 5 -4 -3 -2 -1 -Overall Beat the Market Rank™3.02 out of 5 stars Industry, Sector and Symbol Stock Exchange NYSE Industry Drugs, proprietaries, & sundries Sub-IndustryPersonal Products SectorConsumer Staples Current SymbolNYSE:NUS Previous Symbol CUSIP67018T10 CIK1021561 Webwww.nuskinenterprises.com Phone801-345-1000Debt Debt-to-Equity Ratio0.54 Current Ratio1.74 Quick Ratio1.12Price-To-Earnings Trailing P/E Ratio13.77 Forward P/E Ratio16.82 P/E Growth10.27 Sales & Book Value Annual Sales$2.42 billion Price / Sales0.80 Cash Flow$4.36 per share Price / Cash Flow8.52 Book Value$15.42 per share Price / Book2.41Profitability EPS (Most Recent Fiscal Year)$3.10 Net Income$173.55 million Net Margins6.49% Return on Equity17.91% Return on Assets8.53%Miscellaneous Employees4,900 Outstanding Shares51,899,000Market Cap$1.93 billion Next Earnings Date8/4/2020 (Estimated) OptionableOptionable NUS Rates by TradingView Receive NUS News and Ratings via Email Sign-up to receive the latest news and ratings for NUS and its competitors with MarketBeat's FREE daily newsletter. Nu Skin Enterprises (NYSE:NUS) Frequently Asked Questions How has Nu Skin Enterprises' stock been impacted by COVID-19 (Coronavirus)? Nu Skin Enterprises' stock was trading at $21.06 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, NUS stock has increased by 76.5% and is now trading at $37.18. View which stocks have been most impacted by Coronavirus. Do Wall Street analysts recommend investors buy shares of Nu Skin Enterprises? 7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Nu Skin Enterprises in the last year. There are currently 1 sell rating, 5 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Nu Skin Enterprises. When is Nu Skin Enterprises' next earnings date? Nu Skin Enterprises is scheduled to release its next quarterly earnings announcement on Tuesday, August 4th 2020. View our earnings forecast for Nu Skin Enterprises. How were Nu Skin Enterprises' earnings last quarter? Nu Skin Enterprises, Inc. (NYSE:NUS) released its quarterly earnings data on Wednesday, May, 6th. The company reported $0.36 earnings per share for the quarter, topping the Zacks' consensus estimate of $0.25 by $0.11. The business had revenue of $518.03 million for the quarter, compared to analyst estimates of $477.01 million. Nu Skin Enterprises had a return on equity of 17.91% and a net margin of 6.49%. The firm's revenue was down 16.9% on a year-over-year basis. During the same quarter last year, the company earned $0.77 earnings per share. View Nu Skin Enterprises' earnings history. How often does Nu Skin Enterprises pay dividends? What is the dividend yield for Nu Skin Enterprises? Nu Skin Enterprises declared a quarterly dividend on Wednesday, May 6th. Shareholders of record on Friday, May 29th will be given a dividend of $0.375 per share on Wednesday, June 10th. This represents a $1.50 annualized dividend and a dividend yield of 4.03%. The ex-dividend date of this dividend is Thursday, May 28th. View Nu Skin Enterprises' dividend history. What guidance has Nu Skin Enterprises issued on next quarter's earnings? Nu Skin Enterprises updated its FY20 earnings guidance on Wednesday, May, 6th. The company provided earnings per share (EPS) guidance of $2.05-2.35 for the period, compared to the Thomson Reuters consensus EPS estimate of $1.99. The company issued revenue guidance of $2.17-2.26 billion, compared to the consensus revenue estimate of $2.09 billion. What price target have analysts set for NUS? 7 equities research analysts have issued twelve-month price targets for Nu Skin Enterprises' shares. Their forecasts range from $29.00 to $70.00. On average, they anticipate Nu Skin Enterprises' stock price to reach $40.57 in the next twelve months. This suggests a possible upside of 9.1% from the stock's current price. View analysts' price targets for Nu Skin Enterprises. What are Wall Street analysts saying about Nu Skin Enterprises stock? Here are some recent quotes from research analysts about Nu Skin Enterprises stock: 1. According to Zacks Investment Research, "Nu Skin’s shares have underperformed the industry in the past six months. Headwinds in Mainland China, a soft view for 2020 and currency fluctuations are prime deterrents. The recently completed 100-day government campaign in Mainland China to inspect offerings of the nutrition and direct sales industry led to adversities like limited sales meetings. This took a toll on the company’s third-quarter 2019 results, with revenues and earnings declining year over year. The company also issued a soft view for the fourth quarter and 2020, wherein adverse impacts from currency movements are likely to persist. Nevertheless, the company is on track with product launches and programs to strengthen sales leaders in Mainland China. Also, the company is committed toward boosting customer base, which grew 4% in the third quarter." (11/11/2019) 2. Pivotal Research analysts commented, "We suspect that NUS management has taken an axe to the outlook to avoid having to cut again." (8/7/2019) Has Nu Skin Enterprises been receiving favorable news coverage? Press coverage about NUS stock has trended extremely negative this week, according to InfoTrie Sentiment. The research firm identifies positive and negative press coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Nu Skin Enterprises earned a media sentiment score of -4.0 on InfoTrie's scale. They also gave news articles about the company a news buzz of 1.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the stock's share price in the immediate future. View the latest news aboutNu Skin Enterprises. Are investors shorting Nu Skin Enterprises? Nu Skin Enterprises saw a increase in short interest in May. As of May 15th, there was short interest totaling 2,360,000 shares, an increase of 11.3% from the April 30th total of 2,120,000 shares. Based on an average daily trading volume, of 1,200,000 shares, the short-interest ratio is currently 2.0 days. Approximately 4.8% of the company's shares are sold short. View Nu Skin Enterprises' Current Options Chain. Who are some of Nu Skin Enterprises' key competitors? Some companies that are related to Nu Skin Enterprises include Estee Lauder Companies (EL), Herbalife Nutrition (HLF), Prestige Consumer Healthcare (PBH), USANA Health Sciences (USNA), Inter Parfums (IPAR), Medifast (MED), Revlon (REV), Veru (VERU) and Nature's Sunshine Products (NATR). View all competitors. What other stocks do shareholders of Nu Skin Enterprises own? Based on aggregate information from My MarketBeat watchlists, some companies that other Nu Skin Enterprises investors own include Alibaba Group (BABA), General Electric (GE), Marathon Petroleum (MPC), Herbalife Nutrition (HLF), Baidu (BIDU), Las Vegas Sands (LVS), Netflix (NFLX), Booking (BKNG), Alphabet (GOOG) and Mastercard (MA). Who are Nu Skin Enterprises' key executives? Nu Skin Enterprises' management team includes the following people: Mr. Steven J. Lund, Exec. Chairman (Age 66)Mr. Ritch N. Wood, CEO & Director (Age 53)Mr. Ryan S. Napierski, Pres (Age 45)Mr. Mark H. Lawrence, Exec. VP & CFO (Age 49)Dr. Joseph Y. Chang, Exec. VP of Product Devel. & Chief Scientific Officer (Age 66) What is Nu Skin Enterprises' stock symbol? Nu Skin Enterprises trades on the New York Stock Exchange (NYSE) under the ticker symbol "NUS." Who are Nu Skin Enterprises' major shareholders? Nu Skin Enterprises' stock is owned by a variety of institutional and retail investors. Top institutional investors include BlackRock Inc. (11.50%), Wellington Management Group LLP (5.59%), AQR Capital Management LLC (3.28%), State Street Corp (2.62%), Bank of New York Mellon Corp (1.71%) and Deutsche Bank AG (1.40%). Company insiders that own Nu Skin Enterprises stock include D Matthew Dorny, Edwina D Woodbury, Foulis Greg, Joseph Y Chang, Neil H Offen, Ritch N Wood and Ryan S Napierski. View institutional ownership trends for Nu Skin Enterprises. Which institutional investors are selling Nu Skin Enterprises stock? NUS stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., Two Sigma Investments LP, Mackay Shields LLC, AQR Capital Management LLC, Wasatch Advisors Inc., Aristotle Capital Boston LLC, Wellington Management Group LLP, and Principal Financial Group Inc.. View insider buying and selling activity for Nu Skin Enterprises. Which institutional investors are buying Nu Skin Enterprises stock? NUS stock was acquired by a variety of institutional investors in the last quarter, including Deutsche Bank AG, APG Asset Management N.V., APG Asset Management N.V., APG Asset Management N.V., Prentice Capital Management LP, Aperio Group LLC, Two Sigma Advisers LP, and Morgan Stanley. View insider buying and selling activity for Nu Skin Enterprises. How do I buy shares of Nu Skin Enterprises? Shares of NUS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Nu Skin Enterprises' stock price today? One share of NUS stock can currently be purchased for approximately $37.18. How big of a company is Nu Skin Enterprises? Nu Skin Enterprises has a market capitalization of $1.93 billion and generates $2.42 billion in revenue each year. The company earns $173.55 million in net income (profit) each year or $3.10 on an earnings per share basis. Nu Skin Enterprises employs 4,900 workers across the globe. What is Nu Skin Enterprises' official website? The official website for Nu Skin Enterprises is www.nuskinenterprises.com. How can I contact Nu Skin Enterprises? Nu Skin Enterprises' mailing address is 75 WEST CENTER ST, PROVO UT, 84601. The company can be reached via phone at 801-345-1000 or via email at [email protected] This page was last updated on 5/29/2020 by MarketBeat.com Staff
